Ticker Details
Zai Lab Limited Zai Lab Ltd is a biopharmaceutical company. The company is engaged in discovering or licensing, developing and commercializing proprietary therapeutics in the fields of oncology, autoimmune and infectious diseases.
IPO Date:	September 20, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.92B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.22 | 2.69%
Avg Daily Range (30 D):	$0.62 | 2.92%
Avg Daily Range (90 D):	$0.48 | 2.35%

Institutional Daily Volume
Avg Daily Volume:	.47M
Avg Daily Volume (30 D):	.94M
Avg Daily Volume (90 D):	.82M

Trade Size
Avg Trade Size (Sh.):	74
Avg Trade Size (Sh.) (30 D):	75
Avg Trade Size (Sh.) (90 D):	70

Institutional Trades
Total Institutional Trades:	3,619
Avg Institutional Trade:	$2.48M
Avg Institutional Trade (30 D):	$1.89M
Avg Institutional Trade (90 D):	$2.01M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.55M
Avg Closing Trade (30 D):	$1.68M
Avg Closing Trade (90 D):	$1.69M
Avg Closing Volume:	53.11K

News

Apr 15, 2026 @ 12:00 PM Boehringer Ingelheim and Zai Lab announce Collabor... Source: Na

Feb 5, 2026 @ 2:35 PM $207B Market Shift: The Race for Fast Track Approv... Source: Prnewswire

Sep 11, 2025 @ 12:02 PM Zai Lab's Double Whammy: Earnings Miss, Phase 3 Se... Source: Bamboo Works Benzinga Contributor

Jul 16, 2025 @ 10:51 PM Cancer Pipeline Milestones Coming Fast as Regulato... Source: Prnewswire

Jul 7, 2025 @ 5:00 PM Bispecific Antibody Clinical Trial Pipeline Gains ... Source: Delveinsight

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.17	$-.05	$-.05
Diluted EPS	$-.17	$-.05	$-.05
Revenue	$449.61M	$106.31M	$99.61M
Gross Profit	$254.07M	$58.15M	$61.3M
Net Income / Loss	$-188.21M	$-50.83M	$-51.02M
Operating Income / Loss	$-264.1M	$-76.49M	$-69.39M
Cost of Revenue	$195.54M	$48.16M	$38.32M
Net Cash Flow	$-127.79M	$-46.12M	$-28.63M
PE Ratio